{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:35:50Z","timestamp":1794645350986,"version":"4.9.1"},"reference-count":38,"publisher":"BMJ","issue":"8","funder":[{"name":"Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, Ministry of Health, Labor, and Welfare of Japan","award":["23FC100801"],"award-info":[{"award-number":["23FC100801"]}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["20K07754"],"award-info":[{"award-number":["20K07754"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["20K07898"],"award-info":[{"award-number":["20K07898"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["22K07490"],"award-info":[{"award-number":["22K07490"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2024,2,13]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increased \u2018cortical\u2019 and \u2018peripheral\u2019 excitability are reportedly associated with shorter survival in amyotrophic lateral sclerosis (ALS) patients, suggesting that hyperexcitability contributes to motor neuron death. However, whether upper or lower motor function has a greater impact on survival is unclear. We aimed to investigate the component that strongly impacts the prognosis of ALS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 103 consecutive patients with ALS who underwent cortical (threshold tracking transcranial magnetic stimulation (TMS)) and motor nerve excitability tests were included. Motor cortical excitability was evaluated using short-interval intracortical inhibition (SICI) during TMS. Motor axonal excitability was assessed using the strength-duration time constant (SDTC). Survival time was defined as the time from examination to death or tracheostomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with healthy subjects, patients with ALS had lower SICI and longer SDTC (p&lt;0.05), indicating increased excitability of cortical motor neurons and motor axons. According to the SICI and SDTC findings, patients were divided into the following four groups: \u2018cortical high and peripheral high (high-high)\u2019, \u2018high-low\u2019, \u2018low-high\u2019 and \u2018low-low\u2019 groups. In Kaplan-Meier curves, the \u2018high-high\u2019 and \u2018low-high\u2019 groups showed significantly shorter survival than the other groups. Multivariate analysis revealed that increased cortical (HR=5.3, p&lt;0.05) and peripheral (HR=20.0, p&lt;0.001) excitability were significantly associated with shorter survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with ALS, both motor cortical and peripheral hyperexcitability independently affected survival time, with peripheral hyperexcitability having a greater impact on shorter survival. The modulation of neuronal\/axonal excitability is a potential therapeutic target for ALS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2023-333039","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T13:25:43Z","timestamp":1709126743000},"page":"730-736","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4282-1475","authenticated-orcid":false,"given":"Ryo","family":"Otani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-0412","authenticated-orcid":false,"given":"Kazumoto","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-1994","authenticated-orcid":false,"given":"Yo-Ichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-9444","authenticated-orcid":false,"given":"Tomoki","family":"Suichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Morooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Aotsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Ogushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-8578","authenticated-orcid":false,"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"2024112820003314000_95.8.730.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00465-8"},{"key":"2024112820003314000_95.8.730.2","doi-asserted-by":"crossref","DOI":"10.3390\/ph15040433","article-title":"Neuronal hyperexcitability and free radical toxicity in amyotrophic lateral sclerosis: established and future targets","volume":"15","author":"Shibuya","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2024112820003314000_95.8.730.3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737175.2016.1197774","article-title":"Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis","volume":"16","author":"Noto","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"2024112820003314000_95.8.730.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300901"},{"key":"2024112820003314000_95.8.730.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30115-1"},{"key":"2024112820003314000_95.8.730.6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01141","article-title":"Functional biomarkers for amyotrophic lateral sclerosis","volume":"9","author":"Huynh","year":"2018","journal-title":"Front Neurol"},{"key":"2024112820003314000_95.8.730.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2008.01.011"},{"key":"2024112820003314000_95.8.730.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00014-9"},{"key":"2024112820003314000_95.8.730.9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.clinph.2017.03.004","article-title":"The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis","volume":"128","author":"Shibuya","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"2024112820003314000_95.8.730.10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl024"},{"key":"2024112820003314000_95.8.730.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301782"},{"key":"2024112820003314000_95.8.730.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.04.005"},{"key":"2024112820003314000_95.8.730.13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1152\/jn.00083.2021","article-title":"Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation","volume":"126","author":"Suzuki","year":"2021","journal-title":"J Neurophysiol"},{"key":"2024112820003314000_95.8.730.14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl172"},{"key":"2024112820003314000_95.8.730.15","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20481"},{"key":"2024112820003314000_95.8.730.16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G"},{"key":"2024112820003314000_95.8.730.17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.1.217"},{"key":"2024112820003314000_95.8.730.18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clinph.2019.07.025","article-title":"Standards of instrumentation of EMG","volume":"131","author":"Tankisi","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"2024112820003314000_95.8.730.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1997.277bh.x"},{"key":"2024112820003314000_95.8.730.20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170213"},{"key":"2024112820003314000_95.8.730.21","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhq134"},{"key":"2024112820003314000_95.8.730.22","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/62.10.1041"},{"key":"2024112820003314000_95.8.730.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-006-0365-2"},{"key":"2024112820003314000_95.8.730.24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neucli.2011.03.001","article-title":"Cortical excitability of amyotrophic lateral sclerosis: transcranial magnetic stimulation study","volume":"41","author":"Khedr","year":"2011","journal-title":"Neurophysiol Clin"},{"key":"2024112820003314000_95.8.730.25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002912"},{"key":"2024112820003314000_95.8.730.26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn071"},{"key":"2024112820003314000_95.8.730.27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/acn3.51039","article-title":"Cortical hyperexcitability evolves with disease progression in ALS","volume":"7","author":"Menon","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2024112820003314000_95.8.730.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2012.06.020"},{"key":"2024112820003314000_95.8.730.29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328550"},{"key":"2024112820003314000_95.8.730.30","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002564"},{"key":"2024112820003314000_95.8.730.31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c1dea3"},{"key":"2024112820003314000_95.8.730.32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis: a randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol"},{"key":"2024112820003314000_95.8.730.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.04.017"},{"key":"2024112820003314000_95.8.730.34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt085"},{"key":"2024112820003314000_95.8.730.35","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30054-1"},{"key":"2024112820003314000_95.8.730.36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/21678421.2015.1038277","article-title":"A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: efficacy and safety of sodium channel blocker phase II trial","volume":"16","author":"Shibuya","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2024112820003314000_95.8.730.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109224"},{"key":"2024112820003314000_95.8.730.38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamaneurol.2020.4300","article-title":"Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"78","author":"Wainger","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2023-333039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T23:01:30Z","timestamp":1732834890000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2023-333039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/jnnp-2023-333039"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2023-333039","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]}}}